Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

000000000000000_tttt

Researchers modify T-cells to identify and target multiple sites on leukaemia cells

April 1, 2020 Research and Development Cancer, Cancers, children cancer, leukaemia

Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …
News
pharmafocus_april_2020_cover

The April 2020 issue of Pharmafocus is available to read free online now!

April 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
News
00000000_fda

FDA aims to accelerate COVID-19 therapies with new programme

April 1, 2020 Research and Development COVID-19, FDA, america, coronaviurs

The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …
News
0000000_iran

Europe sells Iran medicine, defying US sanctions

April 1, 2020 Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus

France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …
News
lilly_building_with_american_flag_web

Lilly partners with Sitryx in $880m immunometabolism drug development deal

April 1, 2020 Research and Development Eli Lilly, Sitryx, partnership, pharma

Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …
News

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020 Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
News
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020 Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
News
medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Feature
flag_of_world_health_organization_at_un_city

WHO launches “historic” multinational study to investigate most promising COVID-19 therapies

March 30, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir

The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …
News
usa-4925212_640

US now leads world in COVID-19 cases as report warns it could face 80,000 deaths in four months

March 27, 2020 Medical Communications, Research and Development

The US now leads the world in total number of COVID-19 cases with more than 85,500 positives, ahead of China’s …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …
News
novartis_outside_1

Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy

March 25, 2020 Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy

Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …
News
0000000_1200px-paracetamol_generico

British government protecting high demand medicine for use in COVID-19 patients

March 25, 2020 Research and Development COVID-19, china coronavirus, coronavirus

The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …
News
00_transportation_isolation_system_1

Results released from first clinical trial using Danoprevir to treat COVID-19

March 25, 2020 Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus

The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …
News

FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020 Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026